Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES

(GILD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 30 390 26 107 22 127 22 289 22 391 22 080
EBITDA 21 191 17 317 12 840 13 055 12 490 12 348
Operating profit (EBIT) 20 033 16 031 11 411 11 488 11 257 10 965
Pre-Tax Profit (EBT) 17 097 13 529 7 799 5 351 9 072 8 976
Net income 13 501 4 628 5 455 4 319 6 746 6 903
P/E ratio 7,20x 20,4x 15,0x 18,4x 11,8x 12,0x
EPS ( $ ) 9,94 3,51 4,17 3,58 5,61 5,49
Dividend per Share ( $ ) 1,84 2,08 2,28 2,51 2,74 2,83
Yield 2,57% 2,90% 3,65% 3,81% 4,15% 4,30%
Reference price ( $ ) 71,610 71,640 62,550 65,930 65,930 65,930
Announcement Date 02/07/2017
09:01pm
02/06/2018
09:01pm
02/04/2019
09:01pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - 25 954 - - - -
Finance 3 985 - 2 467 2 986 5 009 3 700
Operating income (EBITDA) 21 191 17 317 12 840 13 055 12 490 12 348
Leverage
(Debt/EBITDA)
- 1,50x - - - -
Capital Expenditure 748 590 924 804 778 756
Free Cash Flow (FCF) 15 921 11 308 7 476 6 828 9 074 9 351
Book Value Per Share (BVPS) ( $ ) 14,8 15,7 16,7 17,2 18,0 19,0
Cash Flow per Share ( $ ) 12,3 9,02 6,42 6,98 7,07 7,18
Announcement Date 02/07/2017
09:01pm
02/06/2018
09:01pm
02/04/2019
09:01pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 83 411 M $ -
Entreprise Value (EV) 80 425 M $ 78 402 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 18,4x 11,8x
Capitalization / Revenue 3,74x 3,73x
EV / Revenue 3,61x 3,59x
EV / EBITDA 6,16x 6,44x
Yield (DPS / Price) 3,81% 4,15%
Price to book (Price / BVPS) 3,82x 3,66x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 51,5% 50,3%
Operating Leverage (Delta EBIT / Delta Sales) 0,92x -
Net Margin (Net Profit / Revenue) 19,4% 30,1%
ROA (Net Profit / Asset) 10,5% 12,6%
ROE (Net Profit / Equities) 33,5% 25,3%
Rate of Dividend 70,2% 48,8%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   3,61% 3,48%
Cash Flow / Sales 39,6% 40,0%
Capital Intensity (Assets / Sales) 1,85x 2,38x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend